Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-18-033606

Options or other derivatives

  • Chief Financial Officer acquired 301,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Foster Jonathan P. Chief Financial Officer 2018-06-06 Grant or award · Stock option (right to buy) +301,000 846,000 D
Loading xslF345X03/tv496090_4.xml…